Full Press Release Details
information: Michael R. Cox
Announces David L. Omachinski Elected to Board
LAFAYETTE, IN, October 14, 2009 - Bioanalytical Systems, Inc.
(Nasdaq: BASI) announced today that David L. Omachinski has been elected to the
Board of Directors of the company.
Omachinski, 57, is currently an executive management consultant. From
1993 to 2005, he served in various executive management positions with Oshkosh
B'Gosh, Inc., including President, Chief Operating Officer, Chief Financial
Officer, Vice President of Finance and Treasurer. Mr. Omachinski also
previously held various executive roles with Schumaker, Romenesko &
Associates, S.C., a Wisconsin-based, full service, regional accounting
very pleased David will be joining the Board. He has broad financial
experience and his knowledge and insights will provide a valuable perspective to
our Board." said BASi Board Chairman William E. Baitinger.
Omachinski also serves on the board of Anchor BanCorp Wisconsin, Inc. since
1999, the University of Wisconsin-Oshkosh Foundation since 2003, and Chamco,
Inc. since 2002. Mr. Omachinski received his Bachelor of Business
Administration from the University of Wisconsin-Oshkosh and is a certified
pharmaceutical development company providing contract research services and
monitoring instruments to the world's leading drug development companies and
medical research organizations. The company focuses on developing
innovative services and products that increase efficiency and reduce the cost of
taking a new drug to market. Visit www.BASInc.com
for more information about BASi.
release contains forward-looking statements that are subject to risks and
uncertainties including, but not limited to
in the market and demand for our products and services, the
development, marketing and sales of products and services, changes in
technology, industry standards and regulatory standards, and various market and
operating risks detailed in the company's filings with the Securities and
Exchange Commission.